The enabling photonics-and-tools layer led on an oversold chip bounce while the pure-play qubit names gave back Thursday's IonQ rip.

Coherent (COHR) led, up 7.2% to $317.36, at the front of an oversold bounce in the photonics-and-semicap complex rather than on any single-name catalyst — the optics group had been sold hard into September and money rotated back into it. That matters to this vertical because the scarce input for quantum hardware is not qubit count in the abstract but the laser, photonic, and metrology stack that controls and reads out those qubits, and Coherent sits on that laser-and-photonics rung. The move ran with the broad chip-equipment bid: Applied Materials (AMAT) +6.5% to $444.57, FormFactor (FORM) +6.1% to $118.38 on cryogenic wafer-probe test, MKS Instruments (MKSI) +4.9% to $252.08 across vacuum and photonics subsystems, and GlobalFoundries (GFS) +4.3% to $47.82 — the enabling layer, not the modalities, doing the work.

ASP Isotopes (ASPI) was the laggard, down 6.3% to $3.04, extending a punishing month that has cut the isotope-enrichment micro-cap by roughly a third. No fresh disclosure drove Friday's decline; the move reads as a continued unwind in a speculative-tier name, best taken qualitatively. Structurally it still maps a genuine chokepoint — isotopically pure silicon-28 and other enriched feedstocks that spin-qubit and some superconducting roadmaps depend on — which is why its guided timeline is the one to watch rather than the daily tape.

The tell of the session was the split between the enablers and the pure-plays: this was the inverse of Thursday, when IonQ's NVIDIA optimization read-through lifted the whole modality cohort. Friday those names gave it back — IonQ (IONQ) −3.0% to $39.13, D-Wave (QBTS) −3.3% to $17.11, Quantinuum (QNT) −5.4% to $51.58, and Infleqtion (INFQ) −4.5% to $13.23 — with IBM (IBM) −3.4% to $229.55 alongside. The offsets were the materials-and-superconductor rung riding the chip bid: ATI Inc. (ATI) +4.4% to $191.63 in specialty alloys and American Superconductor (AMSC) +3.6% to $30.19. The read is coherent: capital paid up for the tools and photonics that gate whether qubits can be built and controlled, and sold the long-duration hardware stories that had run the day before.

The catalysts ahead are legislative and programmatic. Floor votes on the National Quantum Initiative Reauthorization Act (H.R. 8462 / S. 3597) are the near-term policy trigger — the funding-and-priority signal for the US effort. ASP Isotopes has guided first commercial silicon-28 shipments for Q3, the substrate milestone that would put a real number behind today's laggard. The DARPA Quantum Benchmarking Initiative moves toward its Stage C down-select across November and December — the government's hard read on which hardware paths are credible — and Q2B26 Chicago (Dec 8–10) closes the year as the industry's demand-side showcase.